SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-07-172079
Filing Date
2007-08-06
Accepted
2007-08-06 16:45:02
Documents
6
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 494383
2 FIFTH AMENDMENT DATED JULY 1, 2007 TO LOAN AGREEMENT dex10245.htm EX-10.245 11753
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9618
4 SECTION 302 CAO CERTIFICATION dex312.htm EX-31.2 10060
5 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 2661
6 SECTION 906 CAO CERTIFICATION dex322.htm EX-32.2 2828
  Complete submission text file 0001193125-07-172079.txt   532734
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27570 | Film No.: 071028366
SIC: 8731 Services-Commercial Physical & Biological Research